Self-harm in pregnancy and the postnatal year: prevalence and risk factors.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
May 2023
Historique:
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: ppublish

Résumé

Self-harm in pregnancy or the year after birth ('perinatal self-harm') is clinically important, yet prevalence rates, temporal trends and risk factors are unclear. A cohort study of 679 881 mothers (1 172 191 pregnancies) was conducted using Danish population register data-linkage. Hospital treatment for self-harm during pregnancy and the postnatal period (12 months after live delivery) were primary outcomes. Prevalence rates 1997-2015, in women with and without psychiatric history, were calculated. Cox regression was used to identify risk factors. Prevalence rates of self-harm were, in pregnancy, 32.2 (95% CI 28.9-35.4)/100 000 deliveries and, postnatally, 63.3 (95% CI 58.8-67.9)/100 000 deliveries. Prevalence rates of perinatal self-harm in women without a psychiatric history remained stable but declined among women with a psychiatric history. Risk factors for perinatal self-harm: younger age, non-Danish birth, prior self-harm, psychiatric history and parental psychiatric history. Additional risk factors for postnatal self-harm: multiparity and preterm birth. Of psychiatric conditions, personality disorder was most strongly associated with pregnancy self-harm (aHR 3.15, 95% CI 1.68-5.89); psychosis was most strongly associated with postnatal self-harm (aHR 6.36, 95% CI 4.30-9.41). For psychiatric disorders, aHRs were higher postnatally, particularly for psychotic and mood disorders. Perinatal self-harm is more common in women with pre-existing psychiatric history and declined between 1997 and 2015, although not among women without pre-existing history. Our results suggest it may be a consequence of adversity and psychopathology, so preventative intervention research should consider both social and psychological determinants among women with and without psychiatric history.

Sections du résumé

BACKGROUND BACKGROUND
Self-harm in pregnancy or the year after birth ('perinatal self-harm') is clinically important, yet prevalence rates, temporal trends and risk factors are unclear.
METHODS METHODS
A cohort study of 679 881 mothers (1 172 191 pregnancies) was conducted using Danish population register data-linkage. Hospital treatment for self-harm during pregnancy and the postnatal period (12 months after live delivery) were primary outcomes. Prevalence rates 1997-2015, in women with and without psychiatric history, were calculated. Cox regression was used to identify risk factors.
RESULTS RESULTS
Prevalence rates of self-harm were, in pregnancy, 32.2 (95% CI 28.9-35.4)/100 000 deliveries and, postnatally, 63.3 (95% CI 58.8-67.9)/100 000 deliveries. Prevalence rates of perinatal self-harm in women without a psychiatric history remained stable but declined among women with a psychiatric history. Risk factors for perinatal self-harm: younger age, non-Danish birth, prior self-harm, psychiatric history and parental psychiatric history. Additional risk factors for postnatal self-harm: multiparity and preterm birth. Of psychiatric conditions, personality disorder was most strongly associated with pregnancy self-harm (aHR 3.15, 95% CI 1.68-5.89); psychosis was most strongly associated with postnatal self-harm (aHR 6.36, 95% CI 4.30-9.41). For psychiatric disorders, aHRs were higher postnatally, particularly for psychotic and mood disorders.
CONCLUSIONS CONCLUSIONS
Perinatal self-harm is more common in women with pre-existing psychiatric history and declined between 1997 and 2015, although not among women without pre-existing history. Our results suggest it may be a consequence of adversity and psychopathology, so preventative intervention research should consider both social and psychological determinants among women with and without psychiatric history.

Identifiants

pubmed: 37449482
doi: 10.1017/S0033291721004876
pii: S0033291721004876
pmc: PMC10235666
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2895-2903

Subventions

Organisme : National Institute for Health Research
Organisme : Horizon 2020
ID : 891079
Organisme : Health Foundation

Références

Aust N Z J Psychiatry. 2016 Sep;50(9):911-21
pubmed: 26619895
Crisis. 2016 Jul;37(4):256-264
pubmed: 27278571
Philos Trans R Soc Lond B Biol Sci. 2021 Jun 21;376(1827):20200028
pubmed: 33938272
World Psychiatry. 2020 Oct;19(3):313-327
pubmed: 32931106
Arch Womens Ment Health. 2010 Aug;13(4):319-26
pubmed: 20076979
Lancet Psychiatry. 2019 Jul;6(7):573-581
pubmed: 31175059
Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1131-1138
pubmed: 29664233
Eur J Epidemiol. 2014 Aug;29(8):551-8
pubmed: 24407880
Pediatrics. 2006 Sep;118(3):e669-75
pubmed: 16950958
Acta Obstet Gynecol Scand. 2002 Jun;81(6):516-22
pubmed: 12047304
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
Biomed Res Int. 2013;2013:623743
pubmed: 24024205
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347
Arch Womens Ment Health. 2016 Jun;19(3):463-72
pubmed: 26680447
JAMA Psychiatry. 2021 Feb 1;78(2):171-176
pubmed: 33206140
Acta Psychiatr Scand. 1992 Feb;85(2):97-104
pubmed: 1543046
Am J Obstet Gynecol. 2008 Aug;199(2):120.e1-5
pubmed: 18355781
Obstet Gynecol. 2006 May;107(5):984-90
pubmed: 16648400
Nord J Psychiatry. 2014 Nov;68(8):543-8
pubmed: 24520919
Can J Psychiatry. 2019 Nov;64(11):789-797
pubmed: 31184929
J Affect Disord. 2019 Feb 15;245:653-667
pubmed: 30445391
Br J Psychiatry. 2020 Apr;216(4):180-181
pubmed: 31685038
Arch Womens Ment Health. 2016 Oct;19(5):741-51
pubmed: 27324912
Br J Psychiatry. 2001 Jan;178(1):48-54
pubmed: 11136210
Obstet Gynecol. 2016 Dec;128(6):1233-1240
pubmed: 27824771
Arch Womens Ment Health. 2017 Jun;20(3):449-462
pubmed: 28389934
Eur J Epidemiol. 2018 Jan;33(1):27-36
pubmed: 29349587
Psychol Med. 2019 Dec;49(16):2727-2735
pubmed: 30560741
Isr J Health Policy Res. 2018 Jun 25;7(1):34
pubmed: 29936911
J Clin Psychiatry. 2019 Dec 31;81(1):
pubmed: 31917904
Soc Psychiatry Psychiatr Epidemiol. 2020 Apr;55(4):415-421
pubmed: 31654088
J Clin Psychiatry. 2020 May 5;81(3):
pubmed: 32369685
Am J Obstet Gynecol. 2019 Nov;221(5):489.e1-489.e9
pubmed: 31173749
Best Pract Res Clin Obstet Gynaecol. 2018 Oct;52:3-12
pubmed: 29779863
Scand J Public Health. 2011 Jul;39(7 Suppl):54-7
pubmed: 21775352
Am J Epidemiol. 2003 Feb 15;157(4):364-75
pubmed: 12578807
Lancet. 2014 Nov 15;384(9956):1775-88
pubmed: 25455248
Scand J Public Health. 2011 Jul;39(7 Suppl):38-41
pubmed: 21775349
Obstet Gynecol. 1997 Aug;90(2):195-201
pubmed: 9241292
Epidemiol Psychiatr Sci. 2020 Aug 13;29:e154
pubmed: 32787983
Sci Rep. 2016 May 12;6:25770
pubmed: 27173845
BJPsych Open. 2019 Mar;5(2):e21
pubmed: 31068232
J Psychiatr Res. 2017 Jan;84:284-291
pubmed: 27810668

Auteurs

Karyn Ayre (K)

Section of Women's Mental Health, Health Services and Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, Kent, London, UK.

Xiaoqin Liu (X)

National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.

Louise M Howard (LM)

Section of Women's Mental Health, Health Services and Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, Kent, London, UK.

Rina Dutta (R)

South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, Kent, London, UK.
Academic Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.

Trine Munk-Olsen (T)

National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.
Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH